Prognostic factors for late urinary toxicity grade 2-3 after conformal radiation therapy on patients with prostate cancer

International Braz J Urol

Volumn 33, Issue 5, 2007, Pages 652-659

  Nakamura, Ricardo Akiyoshi ^a,b   Monti, Carlos R ^a   Castilho, Lisias N ^a   Trevisan, Felipe A ^a   Valim, Alexandre C ^a   Reinato, Jose A ^a  

^a Radium Oncology Institute   (Brazil)

^b NONE   (Brazil)

Author keywords

Bladder; Prognosis; Prostatic neoplasms; Radiotherapy; Toxicity

Indexed keywords

EID: 36549081433     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/s1677-55382007000500006     Document Type: Article

References (17)

1. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, et al.: Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys. 1995; 32: 3-12.
2. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al.: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002; 53: 1097-105.
3. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, et al.: Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005; 294: 1233-9.
4. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al.: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001; 166: 876-81. Erratum in: J Urol 2001; 166: 1839.
5. Kuban D, Pollack A, Huang E, Levy L, Dong L, Starkschall G, et al.: Hazards of dose escalation in prostate cancer radiotherapy. Int J Radial Oncol Biol Phys. 2003; 57: 1260-8.
6. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I: Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000; 48: 635-42.
7. Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, et al.: Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002; 54: 1314-21.
8. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al.: High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002; 53: 1111-6.
9. Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M: Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 1995; 33: 1109-19.
10. Common Terminology Criteria for Adverse Events v3.0 (CTCAE) http:// ctep.cancer.gov/forms/CTCAEv3.pdf (accessed on 09/June/2005)
11. Koper PC, Jansen P, van Putten W, van Os M, Wijnmaalen AJ, Lebesque JV, et al.: Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol. 2004; 73: 1-9.
12. Boersma LJ, van den Brink M, Bruce AM, Shouman T, Gras L, te Velde A, et al.: Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radial Oncol Biol Phys. 1998; 41: 83-92.
13. Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ: Low-grade toxicity after conformal radiation therapy for prostate cancer - impact of bladder volume. Int J Radiat Oncol Biol Phys. 2006; 64: 835-41.
14. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000; 56: 899-905.
15. ICRU report 50: Prescribing, recording and reporting photon beam therapy. ICRU. 1993.
16. Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, et al.: Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005; 61: 1019-34.
17. Liu M, Pickles T, Agranovich A, Berthelet E, Duncan G, Keyes M, et al.: Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 58: 59-67.